The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the European Union Agency for Law Enforcement Cooperation (Europol) released a new analysis Thursday on the European drug market, with a focus on cannabis. Among many highlights, the report concludes that marijuana products are becoming increasingly potent and diverse, while partnerships between criminal organizations are bringing new security risks in Europe. 

“Cannabis continues to divide public opinion and remains the subject of European and international debate,” EMCDDA director Alexis Goosdeel stated. “Today’s analysis looks at the elements needed to support evidence-based policymaking and preparedness in this complex domain, where the scope of cannabis policies is widening and where products are becoming increasingly potent and diverse. Our new findings come at a time when decision-makers must address a vast array of challenges posed by Europe's largest illicit drug market, from the heavy carbon footprint left by cannabis cultivation to health harms, corruption, and violence on our streets.”

Key Takeaways 

Full story available on

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.